Humanized CD22 transgenic mouse model for in vivo analysis of anti-CD22-based immunotherapy

Eur J Immunol. 2020 Nov;50(11):1834-1837. doi: 10.1002/eji.202048636. Epub 2020 Jul 10.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Autoimmune Diseases / immunology
  • B-Lymphocytes / immunology
  • Humans
  • Immunotherapy / methods
  • Leukemia / immunology
  • Lymphoma, B-Cell / immunology
  • Mice
  • Mice, Transgenic
  • Sialic Acid Binding Ig-like Lectin 2 / immunology*

Substances

  • CD22 protein, human
  • Cd22 protein, mouse
  • Sialic Acid Binding Ig-like Lectin 2